- Home
- AMLX vs FRPT Comparison
AMLX vs FRPT Comparison
Compare AMLX & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | FRPT |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.0B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AMLX | FRPT |
|---|---|---|
| Price | $27.97 | $65.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 18 |
| Target Price | $43.00 | ★ $83.19 |
| AVG Volume (30 Days) | ★ 1.3M | 944.1K |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.46 | ★ 183.87 |
| EPS | N/A | ★ 1.29 |
| Revenue | $380,786,000.00 | ★ $1,102,015,000.00 |
| Revenue This Year | N/A | $11.37 |
| Revenue Next Year | N/A | $8.49 |
| P/E Ratio | ★ N/A | $49.65 |
| Revenue Growth | ★ 1612.94 | 13.01 |
| 52 Week Low | $10.83 | $46.45 |
| 52 Week High | $41.14 | $86.00 |
Technical Indicators
Market Signals| Indicator | AMLX | FRPT |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 52.53 |
| Support Level | $26.12 | $64.33 |
| Resistance Level | $28.60 | $68.77 |
| Average True Range (ATR) | 1.31 | 2.58 |
| MACD | 0.17 | 0.05 |
| Stochastic Oscillator | 54.21 | 55.67 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.